Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.

Just two months into the year, the value of acquisitions of American biotech companies has already exceeded last year's total.
Together, the merged companies would have nine pharmaceutical products with more than $1 billion in annual sales each. The deal is expected to be completed in the third quarter.

No more news to show.